These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33031044)

  • 1. Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic.
    Hsu M; Ahern DK; Suzuki J
    JMIR Ment Health; 2020 Oct; 7(10):e21814. PubMed ID: 33031044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital Phenotyping for Monitoring Mental Disorders: Systematic Review.
    Bufano P; Laurino M; Said S; Tognetti A; Menicucci D
    J Med Internet Res; 2023 Dec; 25():e46778. PubMed ID: 38090800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study.
    Jenciūtė G; Kasputytė G; Bunevičienė I; Korobeinikova E; Vaitiekus D; Inčiūra A; Jaruševičius L; Bunevičius R; Krikštolaitis R; Krilavičius T; Juozaitytė E; Bunevičius A
    JMIR Res Protoc; 2023 Oct; 12():e49096. PubMed ID: 37815850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smartphone and Wearable Device-Based Digital Phenotyping to Understand Substance use and its Syndemics.
    Lee JS; Browning E; Hokayem J; Albrechta H; Goodman GR; Venkatasubramanian K; Dumas A; Carreiro SP; O'Cleirigh C; Chai PR
    J Med Toxicol; 2024 Apr; 20(2):205-214. PubMed ID: 38436819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical Development of Digital Phenotyping Tools for Mental Health Applications: Delphi Study.
    Martinez-Martin N; Greely HT; Cho MK
    JMIR Mhealth Uhealth; 2021 Jul; 9(7):e27343. PubMed ID: 34319252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital phenotyping and the COVID-19 pandemic: Capturing behavioral change in patients with psychiatric disorders.
    Jagesar RR; Roozen MC; van der Heijden I; Ikani N; Tyborowska A; Penninx BWJH; Ruhe HG; Sommer IEC; Kas MJ; Vorstman JAS
    Eur Neuropsychopharmacol; 2021 Jan; 42():115-120. PubMed ID: 33298386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smartphone Ownership, Smartphone Utilization, and Interest in Using Mental Health Apps to Address Substance Use Disorders: Literature Review and Cross-sectional Survey Study Across Two Sites.
    Hsu M; Martin B; Ahmed S; Torous J; Suzuki J
    JMIR Form Res; 2022 Jul; 6(7):e38684. PubMed ID: 35797102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review of Digital Phenotyping and Machine Learning in Psychosis Spectrum Illnesses.
    Benoit J; Onyeaka H; Keshavan M; Torous J
    Harv Rev Psychiatry; 2020; 28(5):296-304. PubMed ID: 32796192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital phenotyping for mental health of college students: a clinical review.
    Melcher J; Hays R; Torous J
    Evid Based Ment Health; 2020 Nov; 23(4):161-166. PubMed ID: 32998937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality.
    Torous J; Bucci S; Bell IH; Kessing LV; Faurholt-Jepsen M; Whelan P; Carvalho AF; Keshavan M; Linardon J; Firth J
    World Psychiatry; 2021 Oct; 20(3):318-335. PubMed ID: 34505369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Potential of Apple SensorKit and Digital Phenotyping Data as New Digital Biomarkers for Mental Health Research.
    Langholm C; Kowatsch T; Bucci S; Cipriani A; Torous J
    Digit Biomark; 2023; 7(1):104-114. PubMed ID: 37901364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance of digital phenotyping linked to a digital pill system to measure PrEP adherence among men who have sex with men with substance use.
    Albrechta H; Goodman GR; Oginni E; Mohamed Y; Venkatasubramanian K; Dumas A; Carreiro S; Lee JS; Glynn TR; O'Cleirigh C; Mayer KH; Fisher CB; Chai PR
    PLOS Digit Health; 2024 Feb; 3(2):e0000457. PubMed ID: 38386618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.
    Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Birchwood M; Briggs A; Bucci S; Cotton S; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung A; Aucott L; Farhall J; Gleeson J
    Health Technol Assess; 2022 May; 26(27):1-174. PubMed ID: 35639493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response.
    McDonnell A; MacNeill C; Chapman B; Gilbertson N; Reinhardt M; Carreiro S
    J Subst Abuse Treat; 2021 May; 124():108226. PubMed ID: 33303253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the utility of digital phenotyping to predict health outcomes in schizophrenia: protocol for the HOPE-S observational study.
    Abdul Rashid NA; Martanto W; Yang Z; Wang X; Heaukulani C; Vouk N; Buddhika T; Wei Y; Verma S; Tang C; Morris RJT; Lee J
    BMJ Open; 2021 Oct; 11(10):e046552. PubMed ID: 34670760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 what have we learned? The rise of social machines and connected devices in pandemic management following the concepts of predictive, preventive and personalized medicine.
    Radanliev P; De Roure D; Walton R; Van Kleek M; Montalvo RM; Santos O; Maddox L; Cannady S
    EPMA J; 2020 Sep; 11(3):311-332. PubMed ID: 32839666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Phenotyping in Livestock Farming.
    Neethirajan S; Kemp B
    Animals (Basel); 2021 Jul; 11(7):. PubMed ID: 34359137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond.
    Bergman BG; Kelly JF
    J Subst Abuse Treat; 2021 Jan; 120():108152. PubMed ID: 33129636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General Practitioners' Perspectives About Remote Dermatology Care During the COVID-19 Pandemic in the Netherlands: Questionnaire-Based Study.
    Tensen E; Kuziemsky C; Jaspers MW; Peute LW
    JMIR Dermatol; 2023 Jun; 6():e46682. PubMed ID: 37632975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective acceptability of digital phenotyping among pregnant and parenting people with opioid use disorder: A multisite qualitative study.
    Charron E; White A; Carlston K; Abdullah W; Baylis JD; Pierce S; Businelle MS; Gordon AJ; Krans EE; Smid MC; Cochran G
    Front Psychiatry; 2023; 14():1137071. PubMed ID: 37139320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.